The real revolution came in 2012, when researchers Jennifer Doudna and Emmanuelle Charpentier harnessed CRISPR, a natural bacterial defense system. In bacteria, CRISPR cuts out invading viruses’ DNA ...

By reactivating a long-lost gene, researchers were able to lower uric acid levels and stop damaging fat accumulation in human ...

Gout is one of the oldest documented human illnesses. It develops when sharp crystals form inside joints, triggering intense swelling and pain, and is ...

A study of mosquitoes’ circadian rhythms finds they hunt differently at different times of day. It could help stop their ...

The FDA’s Marty Makary and Vinay Prasad have laid out a path for CRISPR treatments on demand. An expert weighs in on what it ...

Intellia faces FDA clinical holds on key ATTR studies as it readies crucial HAE data in 2026, making lonvo-z pivotal for its near-term outlook.

Researchers have developed the first bioengineered human bone-marrow model to test CAR T-cell therapies for ­acute myeloid ...

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.

Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common ...

Dyadic International Inc. (($DYAI)) has held its Q3 earnings call. Read on for the main highlights of the call. In a recent earnings call, Dyadic ...

One person’s side effect could be another person’s treatment if we expand our perspective on small molecule drug targets, ...